Inovio shares tumbled 8% after short seller Muddy Waters says don't believe the COVID-19 vaccine hypeMarket Watch • 09/02/20
Competitive Advantages Of Inovio's COVID Vaccine Makes Current Low Price A Buying OpportunitySeeking Alpha • 09/01/20
FDA Head Says A COVID-19 Vaccine Could Get Emergency Approval Without Phase 3 Trial Results: FTBenzinga • 08/31/20
Why Heat Biologics, Inovio Pharmaceuticals, and Novavax Are Getting Clobbered TodayThe Motley Fool • 08/24/20